|
|
 |
|
Viewing report
|
|
|
|
Slovenia Pharmaceuticals and Healthcare Report Q4 2008
Business Monitor International, Oct 2008, Pages: 65
Executive Summary 5
Slovenia Pharmaceuticals And Healthcare Industry SWOT 6
Slovenia Political SWOT 7
Slovenia Economic SWOT 8
Slovenia Business Environment SWOT 9
Pharmaceutical Business Environment Ratings 10
Table: Central And Eastern Europe Pharmaceutical Business Environment Rankings For Q408 10
Limits Of Potential Returns 11
Risks To Realisation Of Returns 11
Slovenia – Market Summary 13
Regulatory Regime 14
Intellectual Property Regime 14
IP Deficiencies 15
Patent Disputes 16
Pricing System 17
Reimbursement Policies 18
Eurozone Entry 19
Industry Developments 21
Epidemiology 21
Table: Leading Causes Of Death In Slovenia, 2002 22
Healthcare Sector 23
Healthcare Provision Developments 23
Healthcare Insurance 23
Healthcare Expenditure 25
Pharmaceutical Industry 25
Recent Industry Developments 26
Medical Devices 27
Industry Forecast Scenario 29
Overall Market Forecast 29
Table: Slovenia - Drug Expenditure Indicators, 2004-2012 (EURmn unless otherwise stated) 30
Key Growth Factors – Industry 31
Table: Slovenia - Health Expenditure Indicators, 2004-2012 (EURmn unless otherwise stated) 32
Macroeconomic Forecast Scenario 33
Table: SLOVENIA - ECONOMIC ACTIVITY 35
Prescription Market Forecast 36
Table: Slovenia - Prescription Market Indicators, 2004-2012 (EURmn unless otherwise stated) 37
OTC Market Forecasts 38
Table: Slovenia - OTC Market Indicators, 2004-2012 (EURmn unless otherwise stated) 39
Patented Market Forecast 40
Table: Patented Drug Market Indicators, 2004-2012 (EURmn unless otherwise stated) 41
Generics Markets Forecast 42
Table: Generic Drug Market Indicators, 2004-2012 (EURmn unless otherwise stated) 42
Export/Import Forecasts 43
Table: Slovenia – Pharmaceutical Trade Indicators, 2004-2012 (EURmn unless otherwise stated) 44
Other Healthcare Data Forecasts 45
Table: Slovenia - Other Health Indicators, 2004-2012 45
Key Risks To BMI’s Forecast Scenario 46
Competitive Landscape 47
Table: Leading Companies In Slovenia 2007 47
Company Profiles 48
Multinational Company Profiles 48
GlaxoSmithKline 48
Sanofi-Aventis 49
Pfizer 50
Novartis 52
Merck & Co 53
Indigenous Company Profiles 54
Krka 54
Lek (Novartis/Sandoz) 58
BMI Forecast Modelling 61
How We Generate Our Pharmaceutical Industry Forecasts 61
Pharmaceutical Business Environment Ratings Methodology 62
Ratings Overview 62
Table: Pharmaceutical Business Environment Indicators 63
Weighting 64
Table: Weighting Of Components 64
Sources 64
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Also available
Slovenia Pharmaceuticals and Healthcare Report Q1 2008
Slovenia Pharmaceuticals and Healthcare Report Q2 2008
Slovenia Pharmaceuticals and Healthcare Report Q3 2008
Customers who bought this item also bought
Krka Generics Company Intelligence Report
Slovenia Pharmaceuticals and Healthcare Report Q1 2009
Slovenia Pharmaceuticals and Healthcare Report Q2 2009
Slovenia Pharmaceuticals and Healthcare Report Q2 2008
Slovenia Pharmaceuticals and Healthcare Report Q1 2008
Slovenia Pharmaceuticals and Healthcare Report Q4 2009
Slovenia Pharmaceuticals and Healthcare Report Q3 2008
The Pharmaceutical Market: Slovenia
Mylan: PharmaVitae Generics Profile
Mylan Laboratories Generics Company Intelligence Report
Acquisition of Generics Business of Merck KGaA by Mylan Laboratories Inc Call - Mylan, Inc. - Earnings Transcript
Generics Series: Generics Trends in the Seven Major Markets and Beyond
|
|
|
|
